Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials.
Badve SV, Bilal A, Lee MMY, Sattar N, Gerstein HC, Ruff CT, McMurray JJV, Rossing P, Bakris G, Mahaffey KW, Mann JFE, Colhoun HM, Tuttle KR, Pratley RE, Perkovic V. Badve SV, et al. Among authors: ruff ct. Lancet Diabetes Endocrinol. 2024 Nov 25:S2213-8587(24)00271-7. doi: 10.1016/S2213-8587(24)00271-7. Online ahead of print. Lancet Diabetes Endocrinol. 2024. PMID: 39608381
Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation: Analysis From COMBINE-AF.
Haller PM, Jarolim P, Palazzolo MG, Bellavia A, Antman EM, Eikelboom J, Granger CB, Harrington J, Healey JS, Hijazi Z, Patel MR, Patel SM, Ruff CT, Wallentin L, Braunwald E, Giugliano RP, Morrow DA. Haller PM, et al. Among authors: ruff ct. J Am Coll Cardiol. 2024 Oct 15;84(16):1528-1540. doi: 10.1016/j.jacc.2024.07.023. Epub 2024 Sep 2. J Am Coll Cardiol. 2024. PMID: 39230543 Clinical Trial.
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design.
Jain SS, Mahaffey KW, Pieper KS, Shimizu W, Potpara T, Ruff CT, Kamel H, Lewis BS, Cornel JH, Kowey PR, Horrow J, Strony J, Plotnikov AN, Li D, Weng S, Donahue J, Gibson CM, Steg PG, Mehran R, Weitz JI, Johnston SC, Hankey GJ, Harrington RA, Lam CSP; LIBREXIA AF Trial Investigators and Committees. Jain SS, et al. Among authors: ruff ct. Am Heart J. 2024 Nov;277:145-158. doi: 10.1016/j.ahj.2024.08.011. Epub 2024 Aug 29. Am Heart J. 2024. PMID: 39214801 Free article. Clinical Trial.
Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF.
Johnson LS, Benz AP, Shoamanesh A, Eikelboom JW, Ezekowitz M, Giugliano RP, Wallentin L, Ruff CT, Lopes RD, Jolly S, Whitlock R, Granger CB, Connolly S, Healey JS. Johnson LS, et al. Among authors: ruff ct. J Am Heart Assoc. 2024 Sep 3;13(17):e034758. doi: 10.1161/JAHA.123.034758. Epub 2024 Aug 27. J Am Heart Assoc. 2024. PMID: 39190578 Free PMC article.
Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials.
Marston NA, Pirruccello JP, Melloni GEM, Kamanu F, Bonaca MP, Giugliano RP, Scirica BM, Wiviott SD, Bhatt DL, Steg PG, Raz I, Braunwald E, Libby P, Ellinor PT, Bick AG, Sabatine MS, Ruff CT. Marston NA, et al. Among authors: ruff ct. Nat Med. 2024 Sep;30(9):2641-2647. doi: 10.1038/s41591-024-03188-z. Epub 2024 Aug 6. Nat Med. 2024. PMID: 39107561 Clinical Trial.
Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation: Post Hoc Analysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial.
Zimerman A, Braunwald E, Steffel J, Van Mieghem NM, Palazzolo MG, Murphy SA, Chen CZL, Unverdorben M, Ruff CT, Antman EM, Giugliano RP. Zimerman A, et al. Among authors: ruff ct. JAMA Cardiol. 2024 Sep 1;9(9):817-825. doi: 10.1001/jamacardio.2024.1793. JAMA Cardiol. 2024. PMID: 38985461 Clinical Trial.
164 results